Investing Profile

Ruchita Sinha

InvestorVC
General Partner at AV8 Ventures
av8.vc/ruchita-sinha/San Francisco Bay Area
Photo of Ruchita Sinha, General Partner at AV8 Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
The University of Chicago Booth School of Business Network
198 CONNECTIONS
University of Wisconsin-Madison Network
110 CONNECTIONS
L.E.K. Consulting Network
72 CONNECTIONS
Pfizer Network
72 CONNECTIONS
Sanofi Network
40 CONNECTIONS
cb
AV8 Ventures General Partner
$500K - $5.0M
$2.0M
4
€150M
CompanyStageDateRound SizeTotal Raised
Shennon Biotechnologies
SeedMar 2023$13M
$13M
Co-investors: James Hardiman (DCVC (Data Collective)), Steve Vassallo (Foundation Capital)
Curisium
SeedDec 2017$4M
$4M
Co-investors: Greg Papadopoulos (New Enterprise Associates (NEA)), Mohamad Makhzoumi (New Enterprise Associates (NEA)), Bill Geary (Flare Capital Partners)
Jiseki Health
SeedMar 2016$50K
$50K
Biome Analytics
SeedMar 2016$50K
$50K
Research Associate MaxygenPresent
Sr. Consultant L.E.K. ConsultingPresent
Director, Strategy, Portfolio Management, and Commercial Operations PfizerPresent
Director, GE Ventures GE VenturesPresent
Board Observer GE VenturesPresent
Board Observer CaremergePresent
Sr. Director of Investments SanofiPresent
Investor EvidationPresent
Board Observer Inozyme PharmaPresent
Board Observer Omada HealthPresent
Board Observer CurisiumPresent
Investor Click Therapeutics, Inc.Present
Investor Aetion, a Datavant CompanyPresent
Advisor Mahana TherapeuticsPresent
Board Member PhenomicPresent
General Partner AV8 VenturesPresent
Venture Partner AV8 VenturesPresent
Senior Partner ArtisPresent
University of Wisconsin-Madison Master of Science - MS Cell/Cellular and Molecular Biology
Mount Holyoke College BS Biochemistry
The University of Chicago Booth School of Business MBA Finance and Entreprenuership
Sign in with Google →
Sign in with Google →